The largest database of trusted experimental protocols

6 protocols using poly l lysine solution 0.1

1

Comprehensive Tissue Preparation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
2,5-Dihydroxybenzoic acid (DHB), norharmane, Fluoroshield with DAPI, Monoclonal Anti-Actin α-Smooth Muscle antibody, LC-MS grade methanol, HPLC grade chloroform, Bouin’s solution, Triton X-100, Tween 20, poly-L-lysine solution 0.1% and Peel-a-Way embedding molds (truncated, 12 × 12 × 20 mm) were purchased from Sigma-Aldrich, Saint Louis, MO, USA. Histology-grade solvents, Eosin G or Y (alcoholic solution 0.5%) and Masson’s Trichrome staining kit were purchased from DiaPath S.p.A., Martinengo, Italy, while QA-Agarose low melting point was obtained from MP Biomedical, Santa Ana, CA, USA. Harris hematoxylin, phosphate buffer saline (PBS) tablets, bovine serum albumin (BSA), SuperFrost Plus glass slides and cover slides were purchased from VWR International, LLC, Radnor, PA, USA. Trifluoroacetic acid (TFA), Antihuman CD68 antibody and AlexaFluor 568 goat anti mouse secondary antibody were purchased from Life Technologies-Invitrogen, Carlsbad, CA, USA. LC-MS grade water was purchased from Thermo Fisher Scientific, Rockford, IL, USA, while ITO coated glass slides for MALDI were obtained from Bruker Daltonics, Billerica, MA, USA. Paraformaldehyde 4% solution was purchased from Alfa Aesar, Haverhill, MA, USA.
+ Open protocol
+ Expand
2

Airway Fluid Sampling for COVID-19 NET Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
As previously described [7 (link)], the airway fluid from 11 patients with COVID-19 patients was obtained by aspiration of the orotracheal tube. This fluid was mixed 1:1 with 0.1 M dithiothreitol (Thermo Fisher Scientific; cat. R0862), incubated for 15 min stirring every 5 min at 37 °C. In the control group (n=8), the airway lavage was obtained by injecting sterile isotonic saline solution through a nasal fossa. The injected solution was mixed with nasal and nasopharyngeal secretions before being evacuated from the other nostril when it was collected directly in a sterile tube. The samples were centrifuged at 750 g at 4 °C for 10 min. The supernatants were used for measurement of NETs, and the cells were fixed for immunostaining in coverslips with Poly-L-lysine solution 0.1% (Sigma-Aldrich; cat P8920).
+ Open protocol
+ Expand
3

Neutrophil Response to SARS-CoV-2 Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neutrophils (106 cells) obtained from COVID-19 patients or healthy controls were incubated with RPMI 1640 supplemented with 0.1% BSA treated or not with Cl-Amidine (200 µM; Sigma-Aldrich; cat. 506282), tenofovir disoproxil fumarate (TDF; 10 µM; as described in Clososki et al., 2020 (link)), neutralizing anti-ACE2 antibody (αACE2; 0.5 µg/ml; Rhea Biotech; cat. IM-0060), Camostat mesylate (Camostat; 10 µM; Sigma-Aldrich; cat. SML0057). All compounds were used 1 h before infection with SARS-CoV-2 (MOI = 1.0) or stimulation with 50 nM PMA. The viral load in cell pellet and concentration of NETs in supernatants was determined 4 h after infection. In another context, neutrophils from healthy controls were incubated with SARS-CoV-2 (MOI = 0.5 and 1.0) for 4 h at 37°C or inactivated SARS-CoV-2. The concentration of NETs in supernatants was determined. A total of 5 × 104 isolated neutrophils were attached to coverslips coated with poly-L-lysine solution 0.1% (Sigma-Aldrich; cat. P8920) incubated for 4 h at 37°C for NET immunostaining.
+ Open protocol
+ Expand
4

Staining and Mounting Nucleated Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The NACs were centrifuged at 800 g for 10 min., washed with PBS, and then suspended in PBS. The smears of cell suspension were prepared on slide glass that was coated with poly-L-lysine solution 0.1% (Sigma-Aldrich, St. Louis, MO, USA). The slides were left to dry, fixed with methanol, and then stained with Wright–Giemsa solution (Muto Pure Chemicals, Japan).
+ Open protocol
+ Expand
5

Investigating SARS-CoV-2 Induced NETosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neutrophils (1x10 6 cells) obtained from COVID-19 patients or healthy controls were incubated with RPMI 1640 supplemented with 0.1% BSA treated or not with Cl-Amidine (200 μM, Sigma-Aldrich, cat. 506282) for 4 h at 37°C. In another context, neutrophils from healthy controls were incubated with SARS-CoV-2 (MOI= 0.5 and 1.0) for 4 h at 37°C or inactivated SARS-CoV-2. The concentration of NETs in supernatants was determined. A total of 5x10 4 isolated neutrophils were attached to coverslips coated with poly-L-lysine solution 0.1% (Sigma-Aldrich, cat. P8920) incubated for 4 h at 37ºC for NETs immunostaining.
+ Open protocol
+ Expand
6

Airway Fluid Analysis of COVID-19 Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
This procedure was performed as previously described (Veras et al., 2020) (link). Briefly, the airway fluid from 11 patients with COVID-19 patients was obtained by aspiration of the . orotracheal tube. This fluid was mixed 1:1 with 0.1 M dithiothreitol (Thermo Fisher Scientific; cat. R0862), incubated for 15 min stirring every 5 min at 37°C. In the control group (n=8), the airway lavage was obtained by injecting sterile isotonic saline solution through a nasal fossa. The injected solution was mixed with nasal and nasopharyngeal secretions before being evacuated from the other nostril when it was collected directly in a sterile tube. The samples were centrifuged 750 g at 4°C for 10 min. The supernatants were used for measurement of NETs and the cells were fixed for immunostaining in coverslips with Poly-L-lysine solution 0.1% (Sigma-Aldrich; cat P8920).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!